PURLs
PURLs
Can extended anticoagulation prophylaxis after discharge prevent thromboembolism?
A meta-analysis confirmed the benefit of thromboprophylaxis with a direct oral anticoagulant for high-risk nonsurgical patients after hospital...
PURLs
Skip that repeat DXA scan in these postmenopausal women
Repeat bone density measurement offers no advantage in predicting fracture risk in postmenopausal women who do not have osteoporosis.
PURLs
Validated scoring system identifies low-risk syncope patients
This study validated the Canadian Syncope Risk Score for predicting 30-day serious outcomes in patients presenting to the ED within 24 hours of...
PURLs
Monotherapy for nonvalvular A-fib with stable CAD?
A meta-analysis found oral anticoagulant (OAC) monotherapy provided efficacy comparable to OAC plus single antiplatelet therapy—with lower...
PURLs
Updated USPSTF screening guidelines may reduce lung cancer deaths
By nearly doubling the number of patients eligible for screening, as many as 60,000 US lives may be saved—but concerns may limit acceptance.
PURLs
This is not the time to modify a HTN regimen
Intensifying hypertension regimens at discharge increases risk in older patients.
PURLs
Prescribe an SGLT2 inhibitor for heart failure in the absence of diabetes?
An RCT demonstrates that dapagliflozin produces better cardiovascular outcomes than placebo for heart failure patients with and without diabetes...
PURLs
Antibiotics and COPD: Time to order a C-reactive protein test?
Consider C-reactive protein–guided prescribing of antibiotics in acute chronic obstructive pulmonary disease exacerbations in the outpatient...
PURLs
Automated office BP measurement: The new standard in HTN screening
Obtain greater accuracy in blood pressure measurement with an automated office device.
PURLs
Confidently rule out CAP in the outpatient setting
A focus on specific signs and symptoms—without imaging—may rule out community-acquired pneumonia in outpatients.
PURLs
An alternative regimen to reduce risk of asthma exacerbations
This study supports the use of an ICS/LABA as needed for adults with intermittent, mild persistent, and moderate persistent asthma.